LOGIN

International Epidemiology Databases to Evaluate AIDS

Home >> Publications >> Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings.

Publication

Author(s):

Semeere AS, Busakhala N, Martin JN.

Pub Title:

Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings.

Pub Date:

Sep 30 2012

Pub Region(s):

East Africa

Journal Issue:

5

Page Number:
522-30

Journal:

Title: 
Current Opinion Oncology
Link: 
http://www.ncbi.nlm.nih.gov/pubmed/22729153

PubMed: 22729153
Pub PDF: PDF icon 22729153.pdf

Abstract
PURPOSE OF REVIEW
: Given the recent availability of antiretroviral therapy (ART) in resource-limited settings and the significant burden exacted by Kaposi's sarcoma in these areas, we reviewed data regarding the impact of ART on Kaposi's sarcoma incidence. We summarized the sizeable literature in resource-rich settings as well as emerging data from resource-limited regions. Importantly, we delineated ways impact can be defined, including individual patient-level effectiveness; population-level effectiveness; change in population-level incidence; and residual risk of Kaposi's sarcoma.

RECENT FINDINGS: In resource-rich settings, there are now ample data demonstrating beneficial individual patient-level and population-level effects of ART on Kaposi's sarcoma incidence. There is, however, considerable variability between studies and important methodologic shortcomings. Data from resource-limited settings are much more limited; although they preliminarily indicate individual patient-level effectiveness, they do not yet provide insight on population-level effects.

SUMMARY: ART has had a substantial impact on Kaposi's sarcoma incidence in resource-rich settings, but more attention is needed on validly quantifying this effect in order to determine whether additional interventions are needed. Emerging data from resource-limited regions also suggest beneficial impact of ART on Kaposi's sarcoma incidence, but - given the scope of Kaposi's sarcoma in these settings - more data are needed to understand the breadth and magnitude of the effect.

PMID: 22729153 [PubMed - indexed for MEDLINE]

PMCID: PMC3418488

 

The following websites provide guidelines and policies when citing from PubMed®: http://www.ncbi.nlm.nih.gov/books/NBK7243/
http://www.nlm.nih.gov/bsd/policy/cit_format.html

Citation:

Semeere AS, Busakhala N, Martin JN. Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings. Curr Opin Oncol. 2012 Sep;24(5):522-30. doi: 10.1097/CCO.0b013e328355e14b. Review. PubMed PMID: 22729153; PubMed Central PMCID: PMC3418488.